Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Disease area: Airway diseases, Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
T. Wang (Taipei, Taiwan), Y. Lo (Taipei, Taiwan), C. Wang (Taipei, Taiwan), H. Kuo (Taipei, Taiwan). Increased CTGF expression of circulating fibrocytes in asthmatic patients with severe OSA - the role of HIF-1a and HDAC7. 2186

Member's Comments

No comment yet.

Related content which might interest you: Reduced expression of the transcription factor KLF4 in COPD macrophages is associated with dysfunctional differentiation Source: International Congress 2017 – Translational studies of lung disease Year: 2017 Activin-A expression is increased in severe asthma and is involved in tissue angiogenesis Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 Decreased expression of VEGFR-2 mRNA in pulmonary vessels of COPD patients Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD Year: 2009 Increased expression of MMP-2 in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 361s Year: 2005 Carbocisteine in vivo reduces circulating miR-21 and IL-8 in exacerbated COPD patients Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 1s Year: 2002 High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 454s Year: 2004 Reduced bronchial epithelial Smad7 protein expression in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 3s Year: 2005 Reduced expression of CD44 on lung macrophages from patients with COPD Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Increased levels of circulating endothelial progenitor cells during exacerbations of COPD Source: Annual Congress 2007 - Biomarkers and assessment of COPD Year: 2007 Elevated expression of TLR4 and HBD2 but decreased levels of IP-10 in COPD with severe exacerbation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Increased interleukin-5 mRNA expression and Bcl-2 depended eosinophils apoptosis suppression in atopic asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 455s Year: 2003 The expression of CD39 mRNA is altered in peripheral blood of patients with allergic asthma Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy Year: 2013 Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 652s Year: 2006 HIF dependent regulation of S100A4 protein in COPD induced vascular remodelling Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Neovascularisation in asthma: Altered angiogenic potential of ASM cells from asthmatic patients Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012 The involvement of thrombospondin-1 in COPD pathogenesis through IL-8 production Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Genes affecting mRNA stability and metalloproteinase inhibitor RECK are down-regulated in patients with COPD Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung Year: 2013 Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Expression of CD38 and its participation in formation of endothelial dysfunction in patients with bronchial asthma Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011